Global Dystrophin Market Size, by Product Type (Exondys51, Translarna, Emflaza), Approach Outlook (Exon Skipping, Anti-Inflammatory Therapy, Stop Codon Read-Through) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1071357
  • |
  • Publishe Date : June 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Dystrophin Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. The market is primarily driven by increasing prevalence of tuberculosis among people. However, high cost related with the tuberculosis treatment and testing might hamper the market growth.

The global dystrophin market is primarily segmented based on different product type, approach outlook and regions.

On the basis of product type, the market is split into:
* Exondys51
* Translarna
* Emflaza
* Others

On the basis of approach outlook, the market is split into:
* Exon Skipping
* Anti-Inflammatory Therapy
* Stop Codon Read-Through
* Others Approaches

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Solid Biosciences Inc
* Catabasis Pharmaceuticals
* Sarepta Therapeutics
* Editas Medicine Inc
* BioMarin Pharmaceutical Inc
* Wave Life Sciences
* Bristol-Myers Squibb
* Pfizer Inc
* PTC Therapeutics
* Asklepios Biopharmaceutical, Inc.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, product type and approach outlook market size and their forecast from 2019-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions, product type and approach outlook with qualitative and quantitative information and facts

Target Audience:
* Dystrophin Manufacturers
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Dystrophin Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global Dystrophin Market - Porter\'s Five Forces Analysis
4.4. Global Dystrophin Market - PESTEL Analysis

5. Global Dystrophin Market, by Product Type
5.1. Global Dystrophin Market, Size and Forecast, 2015-2026
5.2. Global Dystrophin Market, by Exondys51, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global Dystrophin Market, by Translarna, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global Dystrophin Market, by Emflaza, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global Dystrophin Market, by Others, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026

6. Global Dystrophin Market, by Approach Outlook
6.1. Global Dystrophin Market, Size and Forecast, 2015-2026
6.2. Global Dystrophin Market, by Exon Skipping, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global Dystrophin Market, by Anti-Inflammatory Therapy, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026
6.4. Global Dystrophin Market, by Stop Codon Read-Through, 2015-2026
6.4.1. Key driving factors, trends and opportunities
6.4.2. Market size and forecast, 2015-2026
6.5. Global Dystrophin Market, by Others Approaches, 2015-2026
6.5.1. Key driving factors, trends and opportunities
6.5.2. Market size and forecast, 2015-2026

7. Global Dystrophin Market by Region
7.1. Dystrophin Market Regional Analysis, 2015-2026
7.2. Global Dystrophin Market Revenue (USD Million) by Region, 2015-2026
7.3. North America Dystrophin Market, 2015-2026
7.3.1. North America Dystrophin Market Size and Forecast, 2015-2026
7.3.2. North America Dystrophin Market by Country, 2015-2026
7.3.2.1. U.S. Dystrophin Market, 2015-2026
7.3.2.2. Canada Dystrophin Market, 2015-2026
7.4. Europe Dystrophin Market, 2015-2026
7.4.1. Europe Dystrophin Market Size and Forecast, 2015-2026
7.4.2. Europe Dystrophin Market by Country, 2015-2026
7.4.2.1. Germany Dystrophin Market, 2015-2026
7.4.2.2. France Dystrophin Market, 2015-2026
7.4.2.3. Italy Dystrophin Market, 2015-2026
7.4.2.4. UK Dystrophin Market, 2015-2026
7.4.2.5. Spain Dystrophin Market, 2015-2026
7.4.2.6. Rest of Europe Dystrophin Market, 2015-2026
7.5. Asia Pacific Dystrophin Market, 2015-2026
7.5.1. Asia Pacific Dystrophin Market Size and Forecast, 2015-2026
7.5.2. Asia Pacific Dystrophin Market by Country, 2015-2026
7.5.2.1. Japan Dystrophin Market, 2015-2026
7.5.2.2. China Dystrophin Market, 2015-2026
7.5.2.3. India Dystrophin Market, 2015-2026
7.5.2.4. Rest of Asia Pacific Dystrophin Market, 2015-2026
7.6. South America Dystrophin Market, 2015-2026
7.6.1. South America Dystrophin Market Size and Forecast, 2015-2026
7.6.2. South America Dystrophin Market by Country, 2015-2026
7.6.2.1. Mexico Dystrophin Market, 2015-2026
7.6.2.2. Brazil Dystrophin Market, 2015-2026
7.6.2.3. Rest of South America Dystrophin Market, 2015-2026
7.7. Middle East & Africa Dystrophin Market, 2015-2026
7.7.1. Middle East & Africa Dystrophin Market Size and Forecast, 2015-2026
7.7.2. Middle East & Africa Dystrophin Market by Country, 2015-2026
7.7.2.1. Saudi Arabia Dystrophin Market, 2015-2026
7.7.2.2. South Africa Dystrophin Market, 2015-2026
7.7.2.3. Rest of Middle East & Africa Dystrophin Market, 2015-2026

8. Competitive Landscape
8.1. Introduction
8.2. Market Share Analysis/Top Player Positioning, 2019

9. Company Profiles
9.1. Solid Biosciences Inc.
9.1.1. Company Overview
9.1.2. Financial Overview
9.1.3. Product Benchmarking
9.1.4. Key Developments
9.2. Catabasis Pharmaceuticals
9.2.1. Company Overview
9.2.2. Financial Overview
9.2.3. Product Benchmarking
9.2.4. Key Developments
9.3. Sarepta Therapeutics
9.3.1. Company Overview
9.3.2. Financial Overview
9.3.3. Product Benchmarking
9.3.4. Key Developments
9.4. Editas Medicine Inc
9.4.1. Company Overview
9.4.2. Financial Overview
9.4.3. Product Benchmarking
9.4.4. Key Developments
9.5. BioMarin Pharmaceutical Inc
9.5.1. Company Overview
9.5.2. Financial Overview
9.5.3. Product Benchmarking
9.5.4. Key Developments
9.6. Wave Life Sciences
9.6.1. Company Overview
9.6.2. Financial Overview
9.6.3. Product Benchmarking
9.6.4. Key Developments
9.7. Bristol-Myers Squibb
9.7.1. Company Overview
9.7.2. Financial Overview
9.7.3. Product Benchmarking
9.7.4. Key Developments
9.8. Pfizer Inc
9.8.1. Company Overview
9.8.2. Financial Overview
9.8.3. Product Benchmarking
9.8.4. Key Developments
9.9. PTC Therapeutics
9.9.1. Company Overview
9.9.2. Financial Overview
9.9.3. Product Benchmarking
9.9.4. Key Developments
9.10. Asklepios Biopharmaceutical, Inc.
9.10.1. Company Overview
9.10.2. Financial Overview
9.10.3. Product Benchmarking
9.10.4. Key Developments

10. Key Insights

Content are not available

Choose License Type